Abstract

Materials: 1) Screening and early detection especially as it pertains to the incidence, Issues to be presented include: etiology, epidemiology and natural history; 2) How PSA has impacted on the diagnosis and monitoring of patients following treatmens 3) Innovations in surgical technique have reduced the morbidity of surgery as innovations in pathologic evaluation have added questions to the efficacy; 4) The role and limitations of 3-D conformal irradiation; 5) The significance and management of positive post-radiation biopsies; 6) The management of locally advanced prostate cancer will be discussed and the risk benefit ratio of dose escalation, neoadjuvant hormonal therapy, high LET radiation, hyperthermia and interstitial radiation will be presented.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.